Astec Lifesciences Ltd vs Mahamaya Lifesciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 07, 2026

Key Highlights

The Latest Trading Price of Astec Lifesciences Ltd is ₹ 715.65 as of 07 May 15:30 . The P/E Ratio of Astec Lifesciences Ltd changed from 30.1 on March 2021 to -9.8 on March 2025 . This represents a CAGR of NaN% over 5 yearsThe P/E Ratio of Mahamaya Lifesciences Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Astec Lifesciences Ltd changed from ₹ 1959 crore on March 2021 to ₹ 1323 crore on March 2025 . This represents a CAGR of -7.55% over 5 yearsThe Market Cap of Mahamaya Lifesciences Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The revenue of Astec Lifesciences Ltd for the Mar '26 is ₹ 161.26 crore as compare to the Dec '25 revenue of ₹ 125.54 crore. This represent the growth of 28.45% The revenue of Mahamaya Lifesciences Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Astec Lifesciences Ltd for the Mar '26 is ₹ 11.79 crore as compare to the Dec '25 ebitda of ₹ 2.71 crore. This represent the growth of 335.06% The ebitda of Mahamaya Lifesciences Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Astec Lifesciences Ltd changed from ₹ -39.72 crore to ₹ -7.75 crore over 8 quarters. This represents a CAGR of -55.83% The net profit of Mahamaya Lifesciences Ltd changed from ₹ 5.53 crore to ₹ 0 crore over 5 quarters. This represents a CAGR of -100.00% The Dividend Payout of Astec Lifesciences Ltd changed from 4.54 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Mahamaya Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Astec Lifesciences Ltd

Astec LifeSciences Limited was initially incorporated on January 25, 1994 as a private limited Company as 'Urshila Traders Private Limited'.
The Company was originally promoted by Reena Bagai and Avita Fernandes.
Their shareholding was purchased by Ashok Hiremath and Pratap Garud on February 11, 1994.
On August 19, 1994, the name of the Company was changed from Urshila Traders Private Limited to Astec Chemicals Private Limited.
In March 2006, the name was changed from Astec Chemicals Private Limited to Astec LifeSciences Private Limited.

About Mahamaya Lifesciences Ltd

Mahamaya Lifesciences Limited was originally incorporated as a private limited Company as 'Mahamaya Life Sciences Private Limited' by the Assistant Registrar of Companies, NCT Delhi & Haryana, on May 07, 2002.
Further, Company's name was changed from 'Mahamaya Life Sciences Private Limited' to 'Mahamaya Lifesciences Private Limited' dated February 15, 2016.
The status was changed to Public Limited Company on November 19, 2024 by the Central Processing Centre. The Company specializes in manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
The Company began the journey by focusing on import and registration of vital pesticide molecules.
It imported these molecules and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India.

FAQs for the comparison of Astec Lifesciences Ltd and Mahamaya Lifesciences Ltd

Which company has a larger market capitalization, Astec Lifesciences Ltd or Mahamaya Lifesciences Ltd?

Market cap of Astec Lifesciences Ltd is 1,594 Cr while Market cap of Mahamaya Lifesciences Ltd is 435 Cr

What are the key factors driving the stock performance of Astec Lifesciences Ltd and Mahamaya Lifesciences Ltd?

The stock performance of Astec Lifesciences Ltd and Mahamaya Lifesciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Astec Lifesciences Ltd and Mahamaya Lifesciences Ltd?

As of May 7, 2026, the Astec Lifesciences Ltd stock price is INR ₹715.65. On the other hand, Mahamaya Lifesciences Ltd stock price is INR ₹186.15.

How do dividend payouts of Astec Lifesciences Ltd and Mahamaya Lifesciences Ltd compare?

To compare the dividend payouts of Astec Lifesciences Ltd and Mahamaya Lifesciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.